Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms.

Documenti analoghi

• Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.
  di: Buscail, L, et al.
  Pubblicazione: (1994)
• Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5
  di: Cordelier, Pierre, et al.
  Pubblicazione: (1997)
• Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer
  di: O'Byrne, K J, et al.
  Pubblicazione: (1999)
• Expression of Somatostatin Receptor Subtypes (SSTR-1–SSTR-5) in Pediatric Hematological and Oncological Disorders
  di: Harda, Kristof, et al.
  Pubblicazione: (2020)
• Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238
  di: Benali, Naoual, et al.
  Pubblicazione: (2000)